BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37805387)

  • 1. Clinical Applications of Dedicated Breast Positron Emission Tomography.
    Fowler AM; Miyake KK; Nakamoto Y
    PET Clin; 2024 Jan; 19(1):105-117. PubMed ID: 37805387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
    Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
    Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer staging in a single session: whole-body PET/CT mammography.
    Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
    J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of
    Kirchner J; Martin O; Umutlu L; Herrmann K; Bittner AK; Hoffmann O; Mohrmann S; Gauler T; Theurer S; Antke C; Esposito I; Kinner S; Schaarschmidt BM; Kowall B; Lütke-Brintrup D; Stang A; Becker AS; Antoch G; Buchbender C
    Eur J Radiol; 2020 Jul; 128():108975. PubMed ID: 32371185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer.
    Garcia-Velloso MJ; Ribelles MJ; Rodriguez M; Fernandez-Montero A; Sancho L; Prieto E; Santisteban M; Rodriguez-Spiteri N; Idoate MA; Martinez-Regueira F; Elizalde A; Pina LJ
    Eur Radiol; 2017 Aug; 27(8):3190-3198. PubMed ID: 28004161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-fluoro-2-deoxy-D-glucose positron emission tomography versus conventional imaging for the diagnosis of breast cancer and lymph node metastases.
    Shao M; Zi J; Wen G
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S661-S666. PubMed ID: 30249884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging.
    Botsikas D; Kalovidouri A; Becker M; Copercini M; Djema DA; Bodmer A; Monnier S; Becker CD; Montet X; Delattre BM; Ratib O; Garibotto V; Tabouret-Viaud C
    Eur Radiol; 2016 Jul; 26(7):2297-307. PubMed ID: 26477029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical roles of breast 3T MRI, FDG PET/CT, and breast ultrasound for asymptomatic women with an abnormal screening mammogram.
    Chou CP; Peng NJ; Chang TH; Yang TL; Hu C; Lin HS; Huang JS; Pan HB
    J Chin Med Assoc; 2015 Dec; 78(12):719-25. PubMed ID: 26364959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions.
    Scheidhauer K; Walter C; Seemann MD
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S70-9. PubMed ID: 15133634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of Nineteen Different Imaging Methods for Patients with Breast Cancer: a Network Meta-Analysis.
    Zhang XH; Xiao C
    Cell Physiol Biochem; 2018; 46(5):2041-2055. PubMed ID: 29723846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
    Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
    Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
    Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging.
    Heusner TA; Kuemmel S; Koeninger A; Hamami ME; Hahn S; Quinsten A; Bockisch A; Forsting M; Lauenstein T; Antoch G; Stahl A
    Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1077-86. PubMed ID: 20204355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study.
    Satoh Y; Motosugi U; Imai M; Onishi H
    Ann Nucl Med; 2020 Feb; 34(2):119-127. PubMed ID: 31768819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer.
    Yanai A; Itoh M; Hirakawa H; Yanai K; Tashiro M; Harada R; Yoshikawa A; Yamamoto S; Ohuchi N; Ishida T
    Tohoku J Exp Med; 2018 May; 245(1):13-19. PubMed ID: 29731479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
    Park JS; Moon WK; Lyou CY; Cho N; Kang KW; Chung JK
    Acta Radiol; 2011 Feb; 52(1):21-8. PubMed ID: 21498321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of various modalities in breast imaging.
    Prasad SN; Houserkova D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Dec; 151(2):209-18. PubMed ID: 18345253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.